Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts $3.16 +0.01 (+0.16%) As of 01:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals Earnings Summary Rocket Pharmaceuticals posted Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.59, which missed the consensus estimate of -$0.57 by $0.02. With a trailing EPS of -$2.51, Rocket Pharmaceuticals' earnings are expected to grow next year, from ($2.83) to ($2.22) per share. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 7) -$0.57 Actual EPS (Aug. 7) -$0.59 Missed By -$0.02 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)RCKT Upcoming EarningsRocket Pharmaceuticals' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Powered by Get Rocket Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rocket Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataRCKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Rocket Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.84-$0.59-$0.72Q2 20254-$0.79-$0.56-$0.63Q3 20254-$0.81-$0.46-$0.58Q4 20254-$0.77-$0.41-$0.55 FY 2025 14 -$3.21 -$2.02 -$2.48 Q1 20261-$0.27-$0.27-$0.27Q2 20261-$0.07-$0.07-$0.07 Rocket Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/7/2025Q2 2025-$0.57-$0.59 -$0.02-$0.62$4.36M-5/13/2025--$0.58-$0.56+$0.02---5/5/2025Q1 2025-$0.59-$0.56+$0.03-$0.56$0.80M-3/3/2025Q4 2024-$0.68-$0.62+$0.06-$0.62$0.03M-11/7/2024--$0.78-$0.71+$0.07-$0.71--8/5/2024Q2 2024-$0.72-$0.74 -$0.02-$0.74--5/6/2024Q1 2024-$0.67-$0.66+$0.01-$0.66--2/26/2024Q4 2023-$0.78-$0.64+$0.14-$0.64--11/6/2023Q3 2023-$0.81-$0.75+$0.06-$0.75-- Rocket Pharmaceuticals Earnings - Frequently Asked Questions When is Rocket Pharmaceuticals' earnings date? Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on RCKT's earnings history. Did Rocket Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) missed the analysts' consensus estimate of ($0.57) by $0.02 with a reported earnings per share (EPS) of ($0.59). Learn more on analysts' earnings estimate vs. RCKT's actual earnings. How much profit does Rocket Pharmaceuticals generate each year? Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$258.75 million. RCKT has generated -$2.51 earnings per share over the last four quarters. What is Rocket Pharmaceuticals' EPS forecast for next year? Rocket Pharmaceuticals' earnings are expected to grow from ($2.83) per share to ($2.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Janux Therapeutics Earnings Results Arcus Biosciences Earnings Results Syndax Pharmaceuticals Earnings Results Ardelyx Earnings Results Stoke Therapeutics Earnings Results Xeris Biopharma Earnings Results Zymeworks Earnings Results Amylyx Pharmaceuticals Earnings Results Sionna Therapeutics Earnings Results Tilray Brands Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:RCKT) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
